PSA’s ProgrAms and Services
For a complete description of PSA’s programs and services, ref=
er to
the Guide to
PSA’s Programs and Services.
=
Court
Support
PSA gathers and presents vital information about defendants and available release options that assist judicial officers in decision-making<= o:p>
·
Court support components include:
Diagnostic and Release Services
Court Representation
Forensic Analysis and Testimony
=
Defendant
Supervision
·
Defendant supervision programs include:
High Intensity Supervision Program
U.S. District Court Supervision
Specialized Supervision (Mental Healt=
h)
Unit
=
Interventions
and Defendant Support
PSA supervision gives defendants the
opportunity to participate in a variety of pro-social interventions in an
effort to decrease the likelihood of future criminal behavior
·
Interventions and defendant support programs include:
Superior Court Drug Intervention Program=
(Drug
Court)
New Directions Intensive Drug Treatment and
Supervision program
Social Services and Assessment Center<= o:p>
Ordering Treatment Modalities Not Indica=
ted by
an Assessment
Diagnostic and Release Services
PSA’s Diagnostic Un=
it
and Release Services Unit serve both the D.C. Superior Court
(Superior Court) and the U.S. District Court (District Court). Together, they have the primary
functions to:
§Provide court officials with accurate background
information on arrestees and render release recommendations that address bo=
th
safety and appearance considerations;
§Meet with defendants to review their conditions=
of
release and the penalties for not complying with release conditions, failur=
e to
appear and rearrest;
§Assist defendants and the Court to prevent issu=
ance
of bench warrants and assist defendants in surrendering on outstanding D.C.
bench warrants; and
§Make recommendations for citation release.
Diagnostic pretrial services officers are=
in
both courts and interview and investigate the backgrounds of defendants who=
are
arrested on federal, felony and misdemeanor, and D.C./traffic charges and
prepare Pretrial Services Reports (PSRs) to assist judicial officers in set=
ting
release conditions. The pretr=
ial
services officers collect and verify data on a defendant’s community
ties, criminal history, physical and mental health status, substance abuse,=
and
probation, parole and supervised release status and present this informatio=
n in
the PSR. The report also incl=
udes a
detailed recommendation that identifies the various detention and/or
administrative hearings for which the defendant is eligible and conditions =
of
pretrial release PSA determines are needed to minimize the defendant’s
risk of failure to appear in court and/or
rearrest. Copies of the PSR a=
re
given to the Court, defense attorney, and prosecutor.
These interviews comprise approxim=
ately
half of the population scheduled to appear in arraignment court the followi=
ng
day.
PSA uses a risk assessment
instrument that ensures the use of reliable data and identifies the most
appropriate supervision levels of pretrial release for defendants. The risk assessment instrument is
designed to score various risk measures specific to the District’s
defendant population, based on historical trends, resulting in values used =
to
assign defendants to different risk categories and corresponding supervision
assignment to help reduce the risk of failure to appear and rearrest.
In District Court, defendants indicted by=
a
grand jury or those who plead to the charging document that have not been
interviewed by PSA are notified by the Court Clerk’s Office before th=
eir
arraignment/plea dates to contact PSA to arrange an appointment for an
interview. When the Court not=
ice
for the arraignment/plea date is mailed to the defendant, included on the
notice are instructions for either the defendant or defense counsel to cont=
act
the PSA District Court Unit before the arraignment /plea date to arrange fo=
r an
interview.
Pretrial services officers also are prese=
nt
during arraignment in both courts to assist with questions concerning the P=
SR,
provide current drug testing results, and provide recommendations for the
release order for lock-up cases. In
District Court, the pretrial services officer reviews the conditions of rel=
ease
with the defendant while in the courtroom.=
In Superior Court defendants are instructed to report to the Release
Services Unit in room C-301 where their release conditions are reviewed to =
ensure
they are fully understood.
Staff in t=
he
Release Services Unit meet with defendants just released from the courtroom=
and
conduct post-release interviews (PRI).&nbs=
p;
They review the conditions of release with the defendant, and the
repercussions of not complying with release conditions, failure to appear in
court or rearrest. All defend=
ants
should report to this unit immediately following their release after
arraignment, and any time there are subsequent modifications in release in
order to review release conditions and have any questions answered.
The Release
Services Unit also is responsible for the diagnostic investigation and daily
preparation of PSRs for defendants on the daily lock-up list charged with
traffic and D.C. regulatory cases.
Upon request, PSRs also are provided to judges who have defendants
arrested on outstanding bench warrants, but not charged with a Bail Reform =
Act
violation.
Failure-to=
-appear
matters are handled by the Release Services Unit. Whether an inquiry comes from the =
Court
regarding the location of a defendant who is due or a defendant appears who=
has
missed a court date, an investigation is conducted to determine the reason =
for
a defendant’s non-appearance in court. The pertinent information is docum=
ented
and the Court is informed of the findings.=
Defendants sometimes contact PSA and provide information about a fut=
ure
court date where they will be unable to appear. This information is investigated a=
nd
reported to the Court, which can prevent issuance of a bench warrant.
Pretrial services officers in this Unit also investigate Rul=
e 5
matters for defendants arrested in other jurisdictions on D.C. warrants.
Co=
urt
Representation
PSA court representatives are a team of pre=
trial
services officers who are responsible for representing PSA in Superior Court
during judicial proceedings.
Specifically, court representatives are responsible for:
§Obtaining
information for the Court about defendants (e.g., compliance with
release conditions, warrants checks, verifications) and ensuring that
evaluations are completed by the appropriate unit for possible program
placement recommendations;
§Collecting
reports from PSA case managers and ensuring that the Court receives the rep=
orts
by the business day prior to court;
§Ensuring
that a pretrial services officer is present in court in the event that PSA recommends
program placement or any modification of existing release conditions; and
§Ensuring
that the appropriate forms, release orders and any other applicable documen=
ts
are completed and that the copies are distributed to the defendant and his/=
her
attorney along with any necessary written instructions, contact information=
and
directions; and
§Explain
PSA policy and/or program requirements to the Court, defendant or others, a=
s needed.
PSA’s limited resources prevent assignment of court
representatives to each courtroom, so court representatives frequently are
assigned to cover multiple courtrooms on any given day. They ensure that the respective ch=
ambers
and court clerks have their contact information so they can be readily
contacted by cell phone when needed.
Drug
Testing and Compliance<=
/span>
The Drug Testing and Compliance Unit (DTCU) is responsible for the c=
ollection
of urine samples in Superior Court and District Court for defendants arrest=
ed
and charged with a criminal offense, as well as respondents ordered into
testing by the Family Court Division.
In order to achieve its mission, the DTCU is responsible for:
§
Collecting
urine samples from defendants and respondents in lock-up;
§
Processing
defendants and respondents on release with drug testing conditions;
§
Providing
testimony about relevant drug testing and chain-of-custody information to
judicial officers, attorneys, social workers, CSOSA’s community
supervision officers and pretrial services officers;=
§ Referring defendants to case managers due to violations;<= o:p>
§
Providing juvenile criminal histories to PSA’s Diagnostic
Unit and District Court Unit for to be used for bail purposes;
§
Monitoring defendants (PSA does not monitor Family Court
respondents) initial compliance and non-compliance with drug testing
conditions, verifying addresses and court dates; and
§
Investigating the reason for a defendant’s failure to ap=
pear
for drug testing.
Test results used for bail purposes become a part of the=
PSR
to formulate release recommendations.
When the DTCU determines that a defendant reporting for drug testing=
has
an outstanding bench warrant, the DTCU directs him/her to the Release Servi=
ces
Unit for resolution of this warrant.
Forensic Analysis and Testimony<=
/span>
Forensic analysis and testimony are perfo=
rmed
by PSA’s Forensic Toxicology Drug Testing Laboratory (FTDTL), which
serves both PSA and the Court Services and Offender Supervision Agency (CSO=
SA)
by providing:
§Forensic toxicology drug testing and analysis, =
and
§Expert testimony in forensic toxicology at judi=
cial
and administrative proceedings.
The FTDTL is certified by the U.S. Department of Health =
and
Human Services and is staffed by professionals with credentials in forensic
toxicology, forensic science, medical technology, chemistry and biology.
Forensic Analysis
The FTDTL uses Immunoassay and Gas Chroma=
tography
Mass Spectrometry as the primary drug testing methodologies.
§Immunoassay (E=
MIT)
– Metabolism is the process by which the body chemically converts an
ingested drug into water-soluble forms (metabolites), which can be eliminat=
ed
in the urine. The immunoassay=
tests
are designed to identify the principal drug or metabolites that are produced
following ingestion of drugs.
§Gas Chromatography Mass Spectr=
ometry (G=
CMS)
– GCMS is widely recognized in the scientific community as the most s=
pecific,
sensitive technique that exists for determining the chemical structure of a
compound. A GCMS analysis of =
a drug
metabolite is fingerprinting the chemical structure of that
drug on a submolecular basis.
Individual test profiles consist of three or four tests =
for
any combination of the following drugs: cocaine, marijuana, PCP, and
opiates. Positive tests are
retested to validate their accuracy.
When requested for challenge hearings, GCMS is used to confirm posit=
ive
results.
The FTDTL performs tests on over 40,000 specimens each m=
onth
from pretrial defendants as well as probationers, parolees and Family Court
respondents. This translates =
to
approximately 2.5 million analyses of various drugs per year. Two facilities are available for t=
esting
this large volume of work. The
laboratories are located at
Expert Testimony and Consultati=
on
All testimony in support of analytical r=
esults
and interpretation presented in court or at administrative hearings =
is
provided by FTDTL’s expert toxicologists/chemists. FTDTL staff interprets results for=
new
or residual use for over 2,000 defendants/offenders each month.
Designated staff is available for
consultation on matters related to drug testing and interpretation. Pretrial services officers and
CSOSA’s community supervision officers can request information or
consultation via email through the laboratory Help Desk. Defense counsel requesting levels =
checks
must make this request in person at the Lab so that appropriate identificat=
ion
can be established. Requests =
from
prosecutors and defense counsel for drug specimen history reports and/or for
FTDTL personnel to provide expert testimony regarding an interpretation of =
any
report must be made no less than 24 hours in advance of its intended use at=
a
violation hearing, show cause hearing, or challenge hearing. This requirement does not preclude
inquiries that may be made concerning whether a positive drug test result
appears to be new use or is consistent with a residual presence of the
controlled substance, information which is often vital in counsel’s
making a decision whether or not to challenge a particular test result at a
subsequent sanctions hearing.
Gen=
eral Supervision Unit=
The General Supervision Unit (GSU) oversees more than 80 percent of =
the
defendants released to PSA’s supervision. The program actively supervises
compliance with extensive release conditions imposed by Superior Court judi=
cial
officers (e.g., weekly drug testing or in-person reporting with PSA),
notifies the Court, prosecution, and defense counsel of condition violation=
s,
and provides daily courtroom support on pretrial matters to judicial office=
rs. Social
services such as employment counseling also are offered when needed or
requested through referrals to PSA’s Social Services and
Assessment Center (SSAC).
Defendants with monitored release conditions (e.g., verify
address, stay away from a location, or maintain employment) or no release
conditions are notified of their appearance dates and are referred for any
social services if requested by the defendant.
|
Pro=
gram
Summary (Superior Court only) |
|
|
Targeted Defendants |
Eligibility Criteria |
|
§
Any
defendant not released into a specific PSA unit or program. |
§
Any defendant charged with a felony or misdemeanor and
released on non-surety release conditions by the Superior Court. |
|
Supervision
and/or Services Provided |
|
|
§
Attempt =
to
keep defendants in compliance with release conditions; §
Notify t=
he
Court of violations of release conditions; §
Notify t=
he
Court of rearrest; §
Screen
defendants for placement in the High Intensity Supervision Program, New
Directions, §
Refer
defendants who are ineligible for sanction-based treatment to community-b=
ased
treatment; §
Administ=
rative
placement into drug treatment after assessment of defendants referred by =
the
Court or who repeatedly test positive; §
Refer
defendants for social services when needed or requested; and §
Make
appropriate supervision or treatment recommendation when defendants viola=
te
release conditions. |
|
|
Program
Sanctions and/or Incentives |
|
|
Sanctions Responses to infractions include =
the
following sanctions: Drug Testing Contact Incentives §
Reduction in drug testing schedules for defendants who
continue to abstain from drug use. |
|
|
Placement Procedures |
|
|
§
Defendan=
ts released
on non-surety release conditions by the Superior Court are placed into GSU
unless a specific placement into another program has been made. |
For=
more
detailed information, refer to the
Guide to PSAR=
17;s
Programs and Services
Community Court
The East of
the River Community Court (ERCC) has jurisdiction over
|
Pro=
gram
Summary (Superior Court only) |
|
|
Targeted Defendants |
Eligibility Criteria |
|
§ &nbs=
p;
Misdemeanors (excluding
domestic violence) arrested in the 6th and 7th poli=
ce
districts. |
|
|
Supervision
and/or Services Provided |
|
|
§ &nbs=
p;
Attempt to keep defenda=
nts
in compliance with release conditions; § &nbs=
p;
Monitor the deferred
prosecution and deferred sentencing agreements; § &nbs=
p;
Notify the Court of
violations of release conditions; § &nbs=
p;
Notify the Court of
rearrest; § &nbs=
p;
Screen defendants for
placement in the High Intensity Supervision Program, New Directions, § &nbs=
p;
Referrals for and
monitoring of community service for defendants with deferred prosecution =
or
deferred sentencing agreements; § &nbs=
p;
Referrals for housing,
employment, education or other needed social services; §
Administ=
rative
placement into drug treatment after assessment of defendants referred by =
the
Court or who repeatedly test positive; and § |
|
|
Program
Sanctions and/or Incentives |
|
|
Sanctions Responses to infractions include =
the
following sanctions: Drug Testing § &nbs=
p;
Verbal and written warn=
ing; § &nbs=
p;
Warning with a discussi=
on of
treatment needs; § &nbs=
p;
Referral for substance
abuse assessment and possible placement into an appropriate drug treatment
program; and § &nbs=
p;
Termination of the defe=
rred
prosecution and deferred sentencing agreements. Incentives Reduction in drug testing schedules for defendants who conti=
nue
to abstain from drug use. |
|
|
Placement Procedures |
|
|
§ &nbs=
p;
Eligible defendants are
arraigned in the ERCC courtroom. The USAO determines a person’s
eligibility for a deferred prosecution or deferred sentencing agreement. =
The
USAO and the defendant execute the agreement and its requirements. |
For=
more
detailed information, refer to the
Guide to PSAR=
17;s
Programs and Services
Hig=
h Intensity Supervision P=
rogram
The High Intensity Supervision Program (HISP) monitors a
defendant’s compliance with release conditions imposed by the Superior
Court and District Court. The=
program
notifies the Court, prosecution, and defense counsel of program infractions=
and
violations. In addition, HISP
provides immediate sanctions in response to any program infractions.
Case managers in HISP also monitor defendants who are
ordered into Work Release and who reside at a Department of Corrections hal=
fway
house. HISP screens defendant=
s in
halfway houses for placement in HISP or PSA’s drug treatment programs=
.
|
Pro=
gram
Summary (Superior Court and District Court) |
|
|
Targeted Defendants |
Eligibility Criteria |
|
§ &nbs=
p;
Supervision-related
program failures from general supervision, sanction-based treatment contr=
act,
New Directions or § &nbs=
p;
Violent
misdemeanors based on risk assessment; § &nbs=
p;
All
felonies based on risk assessment; and § &nbs=
p;
Compliant
defendants in the halfway house for at least 30 days. |
§ &nbs=
p;
No
outstanding extraditable warrants or detainers; § &nbs=
p;
No
removals from the High Intensity Supervision Program within the past 30 d=
ays;
§ &nbs=
p;
Verified
address with operable landline telephone to monitor curfew; and § &nbs=
p;
Agreement
of homeowner to have electronic monitoring equipment installed. |
|
Supervision
and/or Services Provided |
|
|
§ &nbs=
p;
In-person
contact with case manager; § &nbs=
p;
Drug
testing at least once per week; § &nbs=
p;
Community
phase – Daily electronic monitoring from 10:00 p.m. to 6:00 a.m.; <=
/span> § &nbs=
p;
Home
confinement phase – 24-hour curfew for a 21-day period; § &nbs=
p;
Refer defendants for so=
cial
services or discharge; § &nbs=
p;
Make appropriate
supervision or discharge recommendation when defendants violate release c=
onditions;
and § &nbs=
p;
Notify the Court of
violations on a weekly basis while defendant is in the community phase and
after each infraction when defendant is in the home confinement phase. |
|
|
Program
Sanctions and/or Incentives |
||
|
Sanctions Responses to infractions include =
the
following sanctions: Community Phase: § &nbs=
p;
Verbal
warning; § &nbs=
p;
Modification
of curfew hours to 8:00 pm to 6:00 a.m. § &nbs=
p;
If
the infraction also is the second drug testing infraction, testing will b=
e increased
to twice weekly and require a substance abuse assessment for consideratio=
n of
substance abuse treatment. =
If
treatment is deemed necessary, participation in sanction-based treatment
program is required. § &nbs=
p;
7
days of 24-hour curfew. § &nbs=
p;
14
days of 24-hour curfew. § &nbs=
p;
21
days of 24-hour curfew. § &nbs=
p;
Subsequent
infractions will result in the defendant’s staying under 24-hour cu=
rfew
until a Court hearing. Home
Confinement Phase (24-hour curfew for 21 days): § &nbs=
p;
If
the infraction also is the second drug testing infraction, testing will be
increased is twice weekly and require a substance abuse assessment for
consideration of substance abuse treatment. If treatment is deemed necessary,
participation in sanction-based treatment program is required. § &nbs=
p;
7
additional days of 24-hour curfew. § &nbs=
p;
14
additional days of 24-hour curfew. § &nbs=
p;
21
additional days of 24-hour curfew with report forwarded to the Court
requesting removal from HISP.
Defendant will remain on 24-hour curfew until a hearing is held; e=
ven
in the hearing is not held within the 21-day period. Incentives |
||
|
Placement Procedures |
||
|
§ &nbs=
p;
A
defendant must be screened by PSA. An Attorney Referral Form may be obtai=
ned
through PSA and must be received at least 5 business days prior to the Co=
urt
hearing. § &nbs=
p;
Once
found eligible, PSA provides the necessary release orders to the Court. |
||
For=
more
detailed information, refer to the
Guide to PSAR=
17;s
Programs and Services
Federal defendants under general supervis=
ion
are supervised by PSOs in the District Court Unit (DCU), which is located in
the U.S. District Court building.
The DCU supervises defendants on conditional release from District C=
ourt
and monitors and reports defendants’ compliance to the Court. In addition, DCU voluntarily monit=
ors
defendants on release from other federal districts.
The DCU also arranges for defendants who =
live
in other federal districts to be supervised by the Federal Pretrial Services
Agency in the home district.
|
Pro=
gram
Summary (District Court only) |
|
|
Targeted Defendants |
Eligibility Criteria |
|
§ &nbs=
p;
All defendants on conditional release from District Co=
urt
in the |
§
Federal misdemeanor and felony
charges. |
|
Supervision
and/or Services Provided |
|
|
§ &nbs=
p;
Referrals
to social services providers also are made as
appropriate; and § &nbs=
p;
Appropriate
supervision, treatment or discharge recommendations are made when defenda=
nts
violate release conditions. |
|
|
Program
Sanctions and/or Incentives |
|
|
Sanction=
s Responses to infractions include the following
sanctions: §
Verbal and written warnings; §
Recommendation for a higher level of supervision; and § &nbs=
p;
For those on sanction-based treatment contract; sanctions include =
reorientation,
redirection groups or enhanced treatment and serving a 3-night jail sanct=
ion. Incentiv=
es Reduction =
in
drug testing schedules for defendants who continue to abstain from drug u=
se. |
|
|
Placement Procedures |
|
|
§ &nbs=
p;
Pursuant to a release order indicating extensive relea=
se
conditions; and §
Prior
to placement into sanction-based treatment, defendant is assessed to
determine eligibility and appropriate placement. |
For=
more detailed
information, refer to the
Guide to PSAR=
17;s
Programs and Services
Specialized Supervision (Mental Health) Unit
The
Specialized Supervision Unit (SSU) provides specialized services and
supervision to defendants with mental illness, =
mild mental retardation and/or co-occurring substance
abuse and mental disorders. T=
he SSU
works collaboratively with the Department of Mental Health (DMH), the Mental
Retardation and Developmental Disabilities Administration, and designated
mental health service providers in administering these services. PSA formerly provided mental health
services only through the Options Program, but has expanded its capacity and
services through the SSU.
The Option=
s Program is a separate program within the SSU that has=
a
limited capacity and features a reduced DMH/core service agency caseload ratio to provide intensified supervision
services. A limited number of
housing placements are available.
|
Pro=
gram
Summary (Superior Court and District Court) |
|
|
Targeted Defendants |
Eligibility Criteria |
|
§
Misdemeanor and felonies assessed with mental illness, mild mental
retardation and co-occurring disorders. |
S=
pecialized
Supervision Unit eligible: §
Mild mental retardation; §
Severe, persistent and chronic mental illness; §
Co-occurring substance abuse and mental disorder; and/or §
Found competent or pending determination for competency. O=
ptions
Program eligible*: §
Must self-report or show evidence of mental illness; §
Not already connected to a CSA; §
Connected to a CSA, but agrees to be supervised by Opt=
ions
CSA; §
No primary substance dependence; and §
DC residency is required for services provided through
DMH. * The Options Program is a component of the SSU. |
|
Supervision
and/or Services Provided |
|
|
Specialized Supervision Unit=
§ Case management and referrals to mental health service providers;<= o:p> §
Psychological testing through referrals to the Social Services and=
§
Drug testing and treatment; §
Social service referrals; and §
Monitor deferred prosecution agreements for mentally-ill defendants
placed in the East of the Options Program §
All Specialized Supervision Unit services; §
Transpor=
tation
for defendants from the Court for initial intake with the mental health
service provider; §
Limited
number of housing placements; and §
Reduced
DMH/core service agency caseload ratio to ensure intensive case management and
supervision. |
|
|
Program
Sanctions and/or Incentives |
|
|
§
Individualized therapeutic responses. |
|
|
Placement & Discharge Procedures |
|
|
Placement §
After the defendant is evaluated by DMH or Social Services and Discharge §
If the defendant is sentenced to probation while in mental health
treatment with DMH, SSU’s involvement will be terminated. |
For=
more
detailed information, refer to the
Guide to PSAR=
17;s
Programs and Services
Post-Sentence Supervision
PSA supervises clients charge=
d with
misdemeanor and felony cases throughout the pretrial period until dismissal=
or
sentencing. CSOSA’s Com=
munity
Supervision Program (CSP) takes over supervision following an offender's
probation sentence. The perio=
d of
post-sentence supervision includes probationers pending revocation of
probation. Keeping probation =
cases
with CSP for supervision while the Court considers whether to revoke probat=
ion
should assist with effective supervision.&=
nbsp;
The pretrial services officer no longer has
contact with an offender upon sentencing.&=
nbsp;
The community supervision officer, on the other hand, is more likely=
to
have the most recent involvement and knowledge about the probationer. Moving the probationer back and fo=
rth
between a community supervision officer and a pretrial services offi=
cer causes confusion, which may heighten the risk of fai=
lure
for the offender. Keeping a
probationer with the CSP maintains continuity for that individual as well as
CSP and PSA. Once a judicial
decision is made to revoke probation, it is the expectation of both CSP and=
PSA
that the offender will be stepped back to jail pending re-sentencing if he/=
she
is not re-sentenced immediately. In
addition, PSA is not appropriated resources by Congress and thus is unable =
to
provide treatment or services to offenders in this status.
=
Superior =
Court Drug Intervention Program
(
The Superi=
or
Court Drug Intervention Program (
The Drug Court Misdemeanor Diversion Prog=
ram
is a collaborative effort among the United States Attorney’s Office
(USAO), Superior Court, the defense bar and PSA. Defendants who participate in the
Misdemeanor Diversion Program must be approved for participation by the
USAO. The USAO has sole discr=
etion
to decide when the Misdemeanor Diversion Program is inappropriate for a
particular defendant who may otherwise appear eligible for the program.
If a defendant successfully completes the
Misdemeanor Diversion Program within four to nine months, the government wi=
ll
enter a nolle prosequi. Upon successful completion of the
Program with a felony offense, the chances of a defendant receiving probati=
on
are greatly enhanced, although the actual sentence is at the sole discretio=
n of
the Court.
|
Pro=
gram
Summary (Superior Court only) |
|
|
|
Targeted Defendants |
Eligibility Criteria |
|
|
§ &nbs=
p;
Drug-involved defendant=
s with
non-violent misdemeanor and felony charges. |
§ &nbs=
p;
Positive for drug use at lock-up, initial appearance, =
or
after a random spot test and a current substance abuse assessment
indicating need for treatment; or § &nbs=
p;
At least 3 positive drug tests within 12 months and=
a current substance abuse assessment indicating need for treatment; or § &nbs=
p;
Verified history of drug treatment within 12 months § &nbs=
p;
No serious medical or psychiatric condition preventing
defendant from participating fully in treatment; § &nbs=
p;
No outstanding extraditable warrants or detainers; and=
§ &nbs=
p;
Not currently participating in a methadone maintenance
program. In addition to:<= o:p> § &nbs=
p;
No current charge or pending case involving a violent
misdemeanor, weapons offense, or a violent felony; § &nbs=
p;
All co-defendants must be eligible and agree to
participate in § &nbs=
p;
No more than one additional pending criminal case; § § &nbs=
p;
No prior convictions for a violent felony for which the defendant =
was
serving a sentence; or on probation, parole, or supervised release within=
the
last ten years. |
|
|
Supervision
and/or Services Provided |
||
|
§ &nbs=
p;
Drug testing: regular
weekly testing in phases I, II and III and random testing in phase IV; § &nbs=
p;
Drug treatment: weekly
pursuant to recommended treatment modality; § &nbs=
p;
Supervisory case manager
contact : weekly; &se=
ct; &nbs=
p;
Clinical case manager
contact : weekly; § &nbs=
p;
Referrals to education,
employment, and other social services as deemed necessary; § &nbs=
p;
Participants may also be
required to attend self-help groups, detoxification, inpatient drug treat=
ment
or more intensive outpatient drug treatment; and §
Make appropriate supervision recomm=
endation
when defendants violate release conditions. Random
drug testing is required for all residential placements. |
||
|
Program
Sanctions and/or Incentives |
||
|
Sanctions Current responses to infractions =
include
the following sanctions, or a combination thereof: Drug
Testing § &nbs=
p;
Reorientation
session; § &nbs=
p;
Phase
freeze; § &nbs=
p;
Redirection
groups; § &nbs=
p;
Enhanced
treatment; § &nbs=
p;
2
days jury box; § &nbs=
p;
3
nights in jail; and § &nbs=
p;
Program
discharge. All treatment enhancements ar=
e assessment-driven. Case Manager Contact § &nbs=
p;
Warning
and phase freeze; § &nbs=
p;
Continued
phase freeze; and § &nbs=
p;
Increased
check-in. Incentives § &nbs=
p;
After
16 consecutive negative tests, drug testing is reduced to 1x/week; and af=
ter
4 consecutive negative tests, drug testing is reduced to random testing;<=
/span> § &nbs=
p;
Monthly
Progression Ceremony to recognize all defendants who have advanced to the
next treatment level; and § &nbs=
p;
Upon
completion of the entire program, each defendant=
is
honored in a graduation ceremony attended by family, friends and peers and
presided over by the |
||
|
Placement and Discharge Procedures |
||
|
Placement § &nbs=
p;
Ordered in C-10 after
pretrial screening and from other courtrooms; and pursuant to Drug Court
certification procedures (for pretrial diversion within 15 days of
arraignment for misdemeanors; and within 30 days for felony cases or the =
date
of the first status hearing, whichever is later); § &nbs=
p;
Substance abuse assessm=
ent
must indicate need for treatment; § &nbs=
p;
Prior to the status hearing, § &nbs=
p;
After a trial date has been set, however, the USAO opp=
oses
certification for the Misdemeanor Diversion Program as a matter of course=
. Discharge §
Defendants may be discharged from §
Defendants also must be discharged at t=
heir
request, pursuant to the terms of the contract signed by the defendant. |
For=
more
detailed information, refer to the
Guide to PSAR=
17;s
Programs and Services
New Directions Intensive Dr=
ug
Treatment
The New
Directions Intensive Drug Treatment and Supervision Program (New Directions)
provides sanction-based substance abuse treatment, supervision, and case
management to drug-involved defendants with felony or misdemeanor charges w=
ho
do not otherwise qualify for
Defendants=
may
be required to attend self-help groups, detoxification, intensive outpatien=
t or
inpatient treatment or other residential treatment. Referrals may also be made to educ=
ation,
mental health, employment and other social services.
|
Pro=
gram
Summary (Superior Court and
District Court) |
|
|
Targeted Defendants |
Eligibility Criteria |
|
§ &nbs=
p;
Drug-involved defendants
with felony and misdemeanor charges who do not otherwise qualify for Note: |
§ &nbs=
p;
Positive for drug use at lock-up, initial appearance, =
or
after a random spot test and a current substance abuse assessment =
indicating
need for treatment; or § &nbs=
p;
At least 3 positive drug tests within 12 months and=
a current substance abuse assessment indicating need for treatment; or § &nbs=
p;
Verified history of drug treatment within 12 months § &nbs=
p;
No serious medical or psychiatric condition preventing
defendant from participating fully in treatment; § &nbs=
p;
No outstanding extraditable warrants or detainers; § &nbs=
p;
Not currently participating in a methadone maintenance
program; and § &nbs=
p;
Must be placed prior to conviction. |
|
Supervision
and/or Services Provided |
|
|
§ &nbs=
p;
Drug testing: Regular
weekly testing in phases I, II and III and random testing in phase IV; § &nbs=
p;
Drug treatment: Weekly
pursuant to recommended treatment modality; § &nbs=
p;
Supervisory case manager
contact: Weekly; § &nbs=
p;
Clinical case manager
contact: Monthly; and § &nbs=
p;
Referrals to education,
employment, and other social services as deemed necessary. Random drug testing is required for all
residential placements. |
|
|
Program
Sanctions and/or Incentives |
|
|
Sanction=
s Responses to infractions include =
the
following sanctions: Drug
Testing § &nbs=
p;
Reorientation
session; § &nbs=
p;
Redirection
groups; § &nbs=
p;
Phase
freeze; § &nbs=
p;
Enhanced
treatment; and § &nbs=
p;
Program
discharge. All treatment enhancements are
assessment-driven. Case Manager Contact § &nbs=
p;
Warning
and phase freeze; § &nbs=
p;
Continued
phase freeze; and § &nbs=
p;
Increased
check-in. Incentives § &nbs=
p;
After
16 consecutive negative tests, drug testing is reduced to 1x/week; and af=
ter 4
consecutive negative tests, drug testing is reduced to random testing; § &nbs=
p;
Monthly Progression Ceremony to
recognize all defendants who have advanced to the next treatment level; a=
nd § &nbs=
p;
Upon
completion of the entire program, each defendant is honored in a graduati=
on
ceremony attended by family, friends and peers and presided over by a
Superior Court judge. |
|
|
Placement and Discharge Procedures |
|
|
Placement § &nbs=
p;
The referring § &nbs=
p;
Administrative placemen=
t in
treatment by the pretrial services officer with notice to the Court, or recommendation to the Court fo=
r a
new release order. Discharge &se=
ct; &nbs=
p;
Defendants may be discharged from New
Directions due to non-compliance, the presence of a serious medical and/or
mental health condition, or successful completion of the program. § &nbs=
p;
Defendants also must be discharged at t=
heir
request pursuant to the terms of the contract signed by the defendant. |
For=
more
detailed information, refer to the
Guide to PSAR=
17;s
Programs and Services
Sanction-Based Treatment Unit
The functi=
on
of Sanction-Based Treatment Unit (SBTU) case managers is to monitor
defendants’ compliance with conditions of release, arrange for treatme=
nt
placements, oversee progress in treatment, review drug testing schedules, k=
eep
the court, prosecution and defense apprised of compliance, and provide
incentives and sanctions as warranted.&nbs=
p;
The SBTU staff also makes representations at sanction hearings regar=
ding
defendants’ non-compliance.
|
Pro=
gram
Summary (Superior Court and District Court) |
|
|
Targeted Defendants |
Eligibility Criteria |
|
§ &nbs=
p;
Drug-involved defendants
with felony and misdemeanor charges who do not otherwise qualify for § &nbs=
p;
Defendants who commence
treatment post-conviction; and § &nbs=
p;
Defendants
in methadone maintenance and non-Court ordered drug treatment |
§ &nbs=
p;
At least 3 positive drug tests within 12 months and=
a current substance abuse assessment indicating need for treatment; or § &nbs=
p;
Verified history of drug treatment within 12 months § &nbs=
p;
Positive for drug use on the day of arrest, initial
appearance, or after a random spot test and a current substance ab=
use
assessment indicating need for treatment; § &nbs=
p;
No serious medical or psychiatric condition preventing
defendant from participating fully in treatment; and § &nbs=
p;
No outstanding extraditable warrants or detainers. |
|
Supervision
and/or Services Provided |
|
|
§ &nbs=
p;
Drug testing: Regular
weekly testing if in outpatient treatment, gradually decreasing as defend=
ant
achieves success; § &nbs=
p;
Drug treatment: Weekly
pursuant to recommended treatment modality; and § &nbs=
p;
Referrals to education,=
employment,
and other social services as deemed necessary. Random drug testing by the contracted ven=
dor
is required for all residential placements. |
|
|
Program
Sanctions and/or Incentives |
|
|
Sanctions Responses to infractions include =
the
following sanctions: Drug
Testing § &nbs=
p;
Reorientation
session; § &nbs=
p;
Redirection
groups; § &nbs=
p;
Enhanced
treatment; § &nbs=
p;
2
days jury box; § &nbs=
p;
3
nights in jail; and § &nbs=
p;
Program
discharge. All treatment enhancements are
assessment-driven. Incentives § &nbs=
p;
After
16 consecutive negative tests, drug
testing is reduced to 1x/week; and after 4 consecutive negative tests, dr=
ug
testing is reduced to random testing. |
|
|
Placement and Discharge Procedures |
|
|
Placement § &nbs=
p;
The referring § &nbs=
p;
Administrative placemen=
t in
treatment by the pretrial services officer with notice to the Court or recommendation to the Court for=
a
new release order; and § &nbs=
p;
Defendants
in non-Court ordered treatment may be placed administratively in the SBTU
without a sanction contract Discharge §
Defendants may be discharged from
sanction-based treatment due to non-compliance, the presence of a serious
medical and/or mental health condition, or successful completion of the
program. § &nbs=
p;
Defendants also must be discharged at t=
heir
request pursuant to the terms of the contract signed by the defendant. |
For=
more
detailed information, refer to the
Guide to PSAR=
17;s
Programs and Services
Social Services and
The Social
Services and Assessment Center (SSAC) assists defendants under pret=
rial
release to secure substance abuse treatment assessments, mental health
assessments, employment, housing, or other social services. It =
serves
as a comprehensive treatment assessment center, the PSA repository for
information on community resources, and the primary broker in connecting
defendants with needed social services.
The SSAC also provides community service
opportunities for defendants who are required to perform community service =
as
part of their deferred prosecution or deferred sentencing agreements with t=
he
Superior Court’s East of the River Community Court (ERCC). PSA has identified community
organizations throughout the District that are willing to use the volunteer
services of defendants to perform community service duties. PSA enters into formal agreements =
with
these host organizations and government agencies to establish their willing=
ness
to accept referrals from and to report the defendants’ performance to
PSA. The defendants must perf=
orm
community service with one of the identified host organizations or an
organization approved by the supervising pretrial services officer in order=
to
receive credit for work performed. <=
/span>
|
Pro=
gram
Summary (Superior Court and District Court) |
|
|
Targeted Defendants |
Eligibility Criteria |
|
|
General Services ERCC Community Service |
|
Supervision
and/or Services Provided |
|
|
The
SSAC does not provide supervision. The
following services and referrals are available: §
Comprehensive substance abuse assessment §
Medical referral §
Mental health assessment and referrals §
Social services needs assessment and referral §
Employment services §
Vocational training §
GED preparation §
Community-based skill building groups §
Identification procurement §
Education assistance §
Community service placements (ERCC diversion cases only) §
Housing assistance (subject to availability) |
|
|
Program
Sanctions and/or Incentives |
|
|
Not applicable |
|
|
Referral Procedures |
|
|
§ &nbs=
p;
All SSAC services are available on a walk-in, first co=
me,
first served basis; appointments are neither necessary nor accepted; § &nbs=
p;
To receive services, defendants must be referred by the
Court or the supervising pretrial services officer. Defense counsel may not direct defendants =
to
the SSAC; inste=
ad,
they must request services through the Court or p=
retrial
services officer. |
For=
more
detailed information, refer to the
Guide to PSAR=
17;s
Programs and Services
Ordering Treatment Modalities Not
PSA’s pretrial services officers
administer the assessment and make treatment recommendations based upon
criteria outlined in the American Society of Addiction Medicine (ASAM). On occasion, a judicial officer ma=
y not
agree with PSA's recommended treatment modality. The scenario is usually that the
judicial officer orders the defendant into residential treatment when the P=
SA
assessment indicates a different modality such as outpatient treatment. Should the judicial officer disagr=
ee
with PSA's assessment, or have additional information that should be consid=
ered
for the placement decision, PSA requests that the following procedures be
followed:
1.
Continue the case for 48 hours and schedule anot=
her
hearing;
=
2. Contact the Branch Manager of PSA's=
Treatment
Branch and request that the recommendation be reviewed; and
=
3. Provide any additional information =
the
judicial officer deems appropriate supporting that request for review.
At the continuance hearing, a PSA
representative shall inform the Court of the results of the review and prov=
ide
a recommendation based upon that review.&n=
bsp;
If PSA's review of the assessment does not result in any change in t=
he
recommendation, and the Court so desires, PSA will make every effort to con=
tact
the District’s Addiction and Prevention Recovery Administration to
determine if community-based treatment is an option for the Court to
utilize. PSA is not authorize=
d to
expend federal treatment dollars on a treatment modality that is not suppor=
ted
by the ASAM criteria.
Treatment Resource Timeframes
Substance abuse treatment routinely has b=
een
integrated into pretrial supervision. Unfortunately, treatment demand conti=
nues
to increase, while PSA resources remain constant. Greater demand, coupled with level=
ed
funding, force PSA to adopt procedures that optimally manage its limited
resources. The following time=
frames
for treatment are in place:
§All PSA-funded residential placements to contra=
cted
vendors will not exceed 60 calendar days, unless approved by the PSA Treatm=
ent
Branch Manager.
§PSA case managers will refer sanctions-based
treatment defendants in need of long-term residential/inpatient treatment (=
90
days or more) to the Reentry and
§If ordered by the Court, PSA will fund contract=
ed
treatment if funds are available for a maximum of 30 days following
conviction. PSA will extend t=
hese
placements an additional 30 days if the Court is awaiting completion of a P=
SI
and there is no alternative acceptable to the Court. PSA will continue to
forward funding responsibility to CSOSA for any defendant under contracted
treatment who is sentenced to probation so that treatment can continue
uninterrupted.
§All treatment placements and extensions are ass=
essment-driven.
§PSA will continue to manage defendants in its
non-treatment supervision programs following conviction until sentencing. T=
he